LloydsPharmacy parent company sees profits tumble

Latest

LloydsPharmacy parent company sees profits tumble

In Latest

LloydsPharmacy’s parent company has attributed a 53 per cent year-on-year profit drop in its European division primarily to difficulties in its UK business, singling out NHS “underfunding” and falling prescription numbers as particular challenges.

McKesson’s financial report on the three months to June 30 shows that adjusted operating profits in its European Pharmaceutical Solutions business were $35m (£28.9m) over this period, compared to $74m (£61.1m) in the same period last year.

This earnings slump was “driven by the weak retail pharmacy environment in the UK,” McKesson explained.

In a July 31 conference call with investors, McKesson CEO Brian Tyler said McKesson’s “UK retail business performance” had been hit “primarily by temporary wide NHS underfunding… [and] to a lesser extent volume weakness”.

“Performance in the other European countries was not enough to fully offset these challenges,” Mr Tyler said.

"Rationalising store footprint"

Mr Tyler spoke of actions McKesson had taken “in the UK and across Europe to reposition the business for long-term profitability,” such as recruiting “new leadership” and “further rationalising our store footprint and streamlining our back office functions”.

McKesson will “continue to evaluate our cost structure” in its UK business, he said.

The company recently said that divesting around 200 LloydsPharmacy branches since late 2017 had only been “partially” effective at tackling its problems and that it was looking at “further closures of retail pharmacy stores” in Europe.

“Incrementally positive” signs

Mr Tyler said he believed underfunding issues would “improve in the second half” of the financial year. He said he was “pleased” that Category M prices would increase from August, and that “we would expect to see further upward revisions in tariff later in the year, which should make up partially for any underfunding”.

Turning to the recently announced Communtiy Pharmacy Contractual Framework, he said the five-year deal “brings a greater clarity and long-term certainty,” although certain aspects “are yet to be fully defined and could evolve”. He viewed this as “an incrementally positive development for our UK business”.

Record my learning outcomes

Latest

Inspiring stories related to health, fitness and the pursuit of wellbeing

Share:

More like this

bookmark_icon_off
Latest

New business skills training from Bayer

A new business skills training module for pharmacists is inspired by the finding that small and independent pharmacies are not making best use of technology.

2 Min Article

bookmark_icon_off
Latest

DHSC announces second list of November concessions today

The DHSC has today announded the second wave of price concessions for November.

1 Min Article

bookmark_icon_off
Latest

NHS productivity grows faster than wider economy

A study has shown that the productivity of the NHS has improved almost two and a half times as fast than the wider economy over the last 12 years

1 Min Article

bookmark_icon_off
Latest

Avicenna seeks to sell freehold on 15 branches

The freehold on 15 pharmacies recently acquired by Avicenna will be up for auction next week. 

1 Min Article

bookmark_icon_off
Latest

Demand for pharmacist prescribing rises sharply in Wales

Over 16,000 consultations for pharmacy prescribing services across Wales have taken place in the last four-and-a-half years. 

3 Min Article

bookmark_icon_off
Latest

Pharmacists survey suggests workplace Covid infection common

Four in 10 pharmacists think they caught Covid-19 at work, according to a survey by the PDA. 

2 Min Article

Recommended Learning

bookmark_icon_off
Sponsored Education

Understanding abdominal pain, cramps and IBS

This short video explains the symptoms of irritable bowel syndrome (IBS) and how it differs from abdominal cramps to help you recommend a suitable product for your customer’s needs.

3 Min Module

bookmark_icon_off
Sponsored Education

Next-level parasite protection for dogs

Explore the FRONTLINE Tri-Act® active pack to learn about next-level parasite protection for dogs.

5 Min Module

bookmark_icon_off
Sponsored Education

Managing hay fever: help meet your customers' needs

This module will improve your hay fever knowledge, helping you to understand its impact on sufferers and recommend the right products to ease symptoms

15 Min Module

bookmark_icon_off
Sponsored Education

Pain conversations - making effective recommendations

Explore our detailed case studies to help understand how to advise customers on different causes of pain.

24 Min Module

bookmark_icon_off
Sponsored Education

Managing fever in children

Get to grips with the current guidance on managing fever in children and how antipyretics can help, and discover products you can recommend.

10 Min Module

bookmark_icon_off
Sponsored Education

Learning Resources Pyrocalm

Use these training materials to be confident recommending PPIs to help customers suffering with heartburn and acid reflux, and understand the opportunities OTC omeprazole 20mg offers both customers and pharmacies